Cardio-Phoenix News & Updates

Explore our latest announcements, insights, event highlights, published research, and real-world use cases of Cardio-HART.

Announcement
Cardio-Phoenix secures Angel funding for early heart disease-predicting AI
September 9, 2022
London, Lisbon, Toronto, September 2022. Cardio-Phoenix’s AI assesses novel bio-signals of the heart to predict 14 significant cardiac abnormalities typically diagnosed only by…
Read More
Use Case
Improving early identification of cardiovascular problems at the point-of-care
April 8, 2022
Background Patient 00 has an artificial valve or prosthesis. The patient is under cardiology observation. However, the next cardiology appointment is 6 months…
Read More
Use Case
Breakthrough Cardiac Diagnostic device reduces wait-times and backlog
March 21, 2022
As we cautiously emerge from the grips of the pandemic, so too heart disease is re-emerging as the leading cause of disease burden in England.…
Read More
Publications
Novel tech throws knock-out punch to ECG improving GP referral decisions to cardiology
February 10, 2022
Cardio-HART is the clinician’s AI-powered heart diagnostic assistant. Early detection of heart disease can prolong or increase a patient's quality of life. In addition, it…
Read More
Publications
Cardio-Phoenix secures CE Mark for AI-powered heart diagnostic
December 14, 2020
Cardio-Phoenix recently announced that it received CE Mark approval for its Cardio-Heart heart disease diagnostic device.
Read More
Publications
Telemedicina cardiaca, arriva il dispositivo CHART che rileva il 95% di tutte le malattie del cuore
December 11, 2020
CE-marked approval could change the work of specialists and allow them, at the end of the pandemic, to manage the wave of new heart patients.
Read More

Categories

What makes Cardio-HART a game-changer in early cardiac diagnostics?

Cardio-HART redefines how heart conditions are detected by combining advanced biosignal analysis with AI. Instead of relying solely on ECG, it captures a deeper view of the heart’s mechanical and electrical functions — enabling primary care physicians to detect complex heart diseases earlier, without waiting for specialist referrals.

How does Cardio-HART differ from traditional ECG in real-world studies?

Unlike ECG, Cardio-HART uses AI-driven algorithms combining ECG, PCG, and MCG signals to detect structural and functional heart disorders with higher sensitivity — as validated in multiple studies.

Where has Cardio-HART been presented or featured?

Cardio-HART has been presented at major European cardiology congresses and scientific publications. See our Events and Publications sections for more.

FAQ –>